Skip navigation
Agenda

Industry Best Practices and Strategies for Managing and Enhancing Ethics and Integrity Programs

June 11-12, 2019
  • Toronto, Canada

Agenda

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, JUNE 11, 2019

7:00

Conference Registration and Continental Breakfast

8:00

Conference Co-Chair’s Welcoming and Opening Remarks

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

8:15

BENCHMARKING SESSION
Baseline Key Trends in Canadian Compliance Organizations

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

9:15

PANEL
Explore Other Industry Viewpoints on the Future of Compliance and Ethics

MODERATOR:

Annie Bourgault
President
Integrated Pharma Services, Inc.

PANELISTS:

Ula Ubani
Chief Ethics & Conduct Officer
BMO Financial Group

Carole Chauvin
Ethical Consultant and Co-founder
Groupe Philia, Inc.

10:00

Networking Refreshment Break and Exhibits

10:30

DEEP DIVE WORKSHOP (A – B) CONCURRENT SESSIONS –
PLEASE SELECT ONE

A Assess Next-Level Compliance Monitoring Activities

This session examines opportunities to enhance compliance monitoring activities to the next level and considerations for actions post monitoring activities.

Katie Schottmiller
Director,
Independent Business Monitoring
GSK

 
B Prepare for the Future State of Transparency in Canada —
Lessons Learned From Europe and The U.S.

This session examines the current Canadian transparency reporting landscape. With potential reporting requirements in Ontario stalled and the possibility of transparency initiatives in British Columbia, Manitoba, Quebec and federal intervention, the future of transparency is uncertain.

John Oroho
Executive Vice President and
Chief Strategy Officer
Porzio Life Sciences, LLC

Theodore N. Rosini
Associate
Porzio Life Sciences, LLC

Suzanne Senior-Mitchell
Compliance Counsel, Legal,
Business Ethics & Quality
Novo Nordisk Canada, Inc.

11:45

NETWORKING LUNCHEON & TABLE TALK ROUNDTABLES

Conference participants will have an opportunity to discuss compliance challenges and trends within the following groups: Generics, Medical Devices, Large Pharma and Small/Medium Pharma.

12:45

INTERACTIVE Q & A SESSION
Discuss the Latest Health CanadaPolicy Updates and Initiatives

Alain G. Musende, PhD
Manager, Therapeutic Effectiveness and Policy Bureau
Health Canada

INTERVIEWER:

Jill Daley
General Counsel
Eli Lilly Canada

1:45

Understand Compliance Risk Associated with Patient Support Programs

Chrisoula Nikidis
Canadian Head, Compliance and Ethics
IQVIA Commercial Compliance

Darren Jones
Senior Principal
IQVIA Commercial Compliance

2:45

PANEL
Examine Critical Compliance Issues Around Patient Support Programs,
MSLs and OLAs

MODERATOR:

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

PANELISTS:

Lama Abi Khaled
Executive Director, Ethics, Legal and Regulatory
Innovative Medicines Canada

Shurjeel Choudhri, BSc(med) MD FRCPC
SVP and Head, Medical & Scientific Affairs
Bayer Inc.

Randy Levitt, PhD
Director, Pharmacovigilance and Medical Affairs
Paladin Labs Inc.

Joanne Skedelsky
Head, Pharma Integrity & Compliance, Country Compliance Head
Novartis Pharmaceuticals UK Limited

3:45

Networking and Refreshment Break

4:15

CONCURRENT SESSIONS —
PLEASE SELECT ONE

SESSION I
Educating HCPs Compliantly through OLAs

This session takes a closer look at key differentiators of OLAs.

Chrisoula Nikidis
Canadian Head, Compliance and Ethics
IQVIA Commercial Compliance

Darren Jones
Senior Principal
IQVIA Commercial Compliance

 
SESSION II
Applying Fair Market Value to Manage Risk

As transparency reporting requirements evolve, establishing clear FMV guidelines for HCP engagement can help reduce and manage risk. This session examines industry trends in establishing FMV and how to apply it.

Richard Khambatta
Compliance Officer
Valeant Canada

5:15

PANEL
Examine Key Viewpoints on the State of Transparency in Canada

MODERATOR:

Tim Squire
Partner
Fasken, LLP

PANELISTS:

Russell Williams
Senior Vice President, Mission
Diabetes Canada

Lama Abi Khaled
Executive Director, Ethics, Legal and Regulatory
Innovative Medicines Canada

Nicole DeKort
Vice President, Ontario & Marketing
MEDEC Canada

Close of Day One

Networking, Wine &
Cheese Reception

DAY TWO WEDNESDAY, JUNE 12, 2019

7:30

Continental Breakfast and Networking

8:00

Conference Co-Chair’s Welcoming and Opening Remarks

Stephan Ekmekjian
Heath Care Compliance Officer, Medical Devices Canada
Johnson & Johnson Inc.

8:15

PANEL
Evaluate Industry Partnerships for Physician Education

MODERATOR:

Stephan Ekmekjian
Heath Care Compliance Officer, Medical Devices Canada
Johnson & Johnson Inc.

PANELISTS:

Cécile Bensimon, PhD
Director, Ethics and Professional Affairs
Canada Medical Association

Craig Campbell, MD
Principal Senior Advisor, Competency-based Continuing Professional Development
and Associate Professor, Department of Medicine, Faculty of Medicine,
University of Ottawa

Amy Outschoorn, Med, CTDP
Director, Continuing Professional Development
College of Family Physicians Canada

9:00

DYNAMIC Q & A SESSION
Gain Clarity on New Initiatives at PAAB

INTERVIEWER:

Rosy Sasso
Ethics, Compliance & Privacy Consultant
Rosy Sasso, Inc.

Patrick Massad
Acting Commissioner
PAAB

9:45

Networking and Refreshment Break

10:15

Managing Third-Party Risk

Sara Zborovski
Partner
Norton Rose Fulbright Canada

Vanessa Grant
Partner
Norton Rose Fulbright Canada

11:00

PANEL DISCUSSION
International Perspectives on Compliance and Ethics Trends

MODERATOR:

Rosy Sasso
Ethics, Compliance & Privacy Consultant
Rosy Sasso, Inc.

PANELISTS:

Alexandre C. Serpa, CCEP, CFE, CPC-A
Latin America and Canada Regional Compliance Head
Allergan

Katherine Nunner
Consultant
C&M International

Holger Diener
Managing Director
Association of Voluntary Self-Regulation
for the Pharmaceutical Industry

11:45

Update — Bill 92 Regulations

Mathieu Gagné, LLM, LLD
Partner
Fasken, LLP

Martin Forget
Ethics and Compliance Office
Otsuka Canada Pharmaceuticals

12:00

NETWORKING LUNCHEON & TABLE TALK ROUNDTABLES

Conference participants will have an opportunity to discuss compliance challenges and trends within the following groups: Generics, Medical Devices, Large Pharma and Small/Medium Pharma.

1:30

PANEL
Understand a Joint Hospital and University Approach to Managing
Conflict of Interest

MODERATOR:

Stephan Ekmekjian
Heath Care Compliance Officer, Medical Devices Canada
Johnson & Johnson Inc.

PANELISTS:

Tamara Birkenheier, LLB
Director, Legal and Compliance, Sunnybrook Health Sciences Centre
Sunnybrook Research Institute

Wendy A. Lawrence
Director, Compliance, Privacy & Risk Management
The Hospital for Sick Children

2:15

PANEL
Forward Thinking — Best Practices for Collaborating with Business Partners

MODERATOR:

Annie Bourgault
President
Integrated Pharma Services, Inc.

PANELISTS:

Elizabeth Gill
Global Business Ethics and Compliance Officer
Apotex

Dan Clow
Director, Ethics and Compliance
GSK Canada Pharma

Myriam Prescott
Director, Integrity and Compliance
Novartis Pharma Canada

James R. Wilson
General Manager
Wright Medical Group

3:00

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE TUESDAY, JUNE 11, 2019

7:00

Conference Registration and Continental Breakfast

8:00

Conference Co-Chair’s Welcoming and Opening Remarks

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

8:15

BENCHMARKING SESSION
Baseline Key Trends in Canadian Compliance Organizations

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

9:15

PANEL
Explore Other Industry Viewpoints on the Future of Compliance and Ethics

MODERATOR:

Annie Bourgault
President
Integrated Pharma Services, Inc.

PANELISTS:

Ula Ubani
Chief Ethics & Conduct Officer
BMO Financial Group

Carole Chauvin
Ethical Consultant and Co-founder
Groupe Philia, Inc.

10:00

Networking Refreshment Break and Exhibits

10:30

DEEP DIVE WORKSHOP (A – B) CONCURRENT SESSIONS –
PLEASE SELECT ONE

A Assess Next-Level Compliance Monitoring Activities

This session examines opportunities to enhance compliance monitoring activities to the next level and considerations for actions post monitoring activities.

Katie Schottmiller
Director,
Independent Business Monitoring
GSK

 
B Prepare for the Future State of Transparency in Canada —
Lessons Learned From Europe and The U.S.

This session examines the current Canadian transparency reporting landscape. With potential reporting requirements in Ontario stalled and the possibility of transparency initiatives in British Columbia, Manitoba, Quebec and federal intervention, the future of transparency is uncertain.

John Oroho
Executive Vice President and
Chief Strategy Officer
Porzio Life Sciences, LLC

Theodore N. Rosini
Associate
Porzio Life Sciences, LLC

Suzanne Senior-Mitchell
Compliance Counsel, Legal,
Business Ethics & Quality
Novo Nordisk Canada, Inc.

11:45

NETWORKING LUNCHEON & TABLE TALK ROUNDTABLES

Conference participants will have an opportunity to discuss compliance challenges and trends within the following groups: Generics, Medical Devices, Large Pharma and Small/Medium Pharma.

12:45

INTERACTIVE Q & A SESSION
Discuss the Latest Health CanadaPolicy Updates and Initiatives

Alain G. Musende, PhD
Manager, Therapeutic Effectiveness and Policy Bureau
Health Canada

INTERVIEWER:

Jill Daley
General Counsel
Eli Lilly Canada

1:45

Understand Compliance Risk Associated with Patient Support Programs

Chrisoula Nikidis
Canadian Head, Compliance and Ethics
IQVIA Commercial Compliance

Darren Jones
Senior Principal
IQVIA Commercial Compliance

2:45

PANEL
Examine Critical Compliance Issues Around Patient Support Programs,
MSLs and OLAs

MODERATOR:

Derek Frueh
Director, Ethics and Compliance
Astellas Pharma Canada

PANELISTS:

Lama Abi Khaled
Executive Director, Ethics, Legal and Regulatory
Innovative Medicines Canada

Shurjeel Choudhri, BSc(med) MD FRCPC
SVP and Head, Medical & Scientific Affairs
Bayer Inc.

Randy Levitt, PhD
Director, Pharmacovigilance and Medical Affairs
Paladin Labs Inc.

Joanne Skedelsky
Head, Pharma Integrity & Compliance, Country Compliance Head
Novartis Pharmaceuticals UK Limited

3:45

Networking and Refreshment Break

4:15

CONCURRENT SESSIONS —
PLEASE SELECT ONE

SESSION I
Educating HCPs Compliantly through OLAs

This session takes a closer look at key differentiators of OLAs.

Chrisoula Nikidis
Canadian Head, Compliance and Ethics
IQVIA Commercial Compliance

Darren Jones
Senior Principal
IQVIA Commercial Compliance

 
SESSION II
Applying Fair Market Value to Manage Risk

As transparency reporting requirements evolve, establishing clear FMV guidelines for HCP engagement can help reduce and manage risk. This session examines industry trends in establishing FMV and how to apply it.

Richard Khambatta
Compliance Officer
Valeant Canada

5:15

PANEL
Examine Key Viewpoints on the State of Transparency in Canada

MODERATOR:

Tim Squire
Partner
Fasken, LLP

PANELISTS:

Russell Williams
Senior Vice President, Mission
Diabetes Canada

Lama Abi Khaled
Executive Director, Ethics, Legal and Regulatory
Innovative Medicines Canada

Nicole DeKort
Vice President, Ontario & Marketing
MEDEC Canada

Close of Day One

Networking, Wine &
Cheese Reception

DAY TWO WEDNESDAY, JUNE 12, 2019

7:30

Continental Breakfast and Networking

8:00

Conference Co-Chair’s Welcoming and Opening Remarks

Stephan Ekmekjian
Heath Care Compliance Officer, Medical Devices Canada
Johnson & Johnson Inc.

8:15

PANEL
Evaluate Industry Partnerships for Physician Education

MODERATOR:

Stephan Ekmekjian
Heath Care Compliance Officer, Medical Devices Canada
Johnson & Johnson Inc.

PANELISTS:

Cécile Bensimon, PhD
Director, Ethics and Professional Affairs
Canada Medical Association

Craig Campbell, MD
Principal Senior Advisor, Competency-based Continuing Professional Development
and Associate Professor, Department of Medicine, Faculty of Medicine,
University of Ottawa

Amy Outschoorn, Med, CTDP
Director, Continuing Professional Development
College of Family Physicians Canada

9:00

DYNAMIC Q & A SESSION
Gain Clarity on New Initiatives at PAAB

INTERVIEWER:

Rosy Sasso
Ethics, Compliance & Privacy Consultant
Rosy Sasso, Inc.

Patrick Massad
Acting Commissioner
PAAB

9:45

Networking and Refreshment Break

10:15

Managing Third-Party Risk

Sara Zborovski
Partner
Norton Rose Fulbright Canada

Vanessa Grant
Partner
Norton Rose Fulbright Canada

11:00

PANEL DISCUSSION
International Perspectives on Compliance and Ethics Trends

MODERATOR:

Rosy Sasso
Ethics, Compliance & Privacy Consultant
Rosy Sasso, Inc.

PANELISTS:

Alexandre C. Serpa, CCEP, CFE, CPC-A
Latin America and Canada Regional Compliance Head
Allergan

Katherine Nunner
Consultant
C&M International

Holger Diener
Managing Director
Association of Voluntary Self-Regulation
for the Pharmaceutical Industry

11:45

Update — Bill 92 Regulations

Mathieu Gagné, LLM, LLD
Partner
Fasken, LLP

Martin Forget
Ethics and Compliance Office
Otsuka Canada Pharmaceuticals

12:00

NETWORKING LUNCHEON & TABLE TALK ROUNDTABLES

Conference participants will have an opportunity to discuss compliance challenges and trends within the following groups: Generics, Medical Devices, Large Pharma and Small/Medium Pharma.

1:30

PANEL
Understand a Joint Hospital and University Approach to Managing
Conflict of Interest

MODERATOR:

Stephan Ekmekjian
Heath Care Compliance Officer, Medical Devices Canada
Johnson & Johnson Inc.

PANELISTS:

Tamara Birkenheier, LLB
Director, Legal and Compliance, Sunnybrook Health Sciences Centre
Sunnybrook Research Institute

Wendy A. Lawrence
Director, Compliance, Privacy & Risk Management
The Hospital for Sick Children

2:15

PANEL
Forward Thinking — Best Practices for Collaborating with Business Partners

MODERATOR:

Annie Bourgault
President
Integrated Pharma Services, Inc.

PANELISTS:

Elizabeth Gill
Global Business Ethics and Compliance Officer
Apotex

Dan Clow
Director, Ethics and Compliance
GSK Canada Pharma

Myriam Prescott
Director, Integrity and Compliance
Novartis Pharma Canada

James R. Wilson
General Manager
Wright Medical Group

3:00

Close of Conference